Shoulder Innovations, Inc. earnings per share and revenue
On Nov 11, 2025, SI reported earnings of -0.64 USD per share (EPS) for Q3 25, missing the estimate of -0.31 USD, resulting in a -101.77% surprise. Revenue reached 11.76 million, compared to an expected 10.17 million, with a 15.57% difference. The market reacted with a +32.04% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -0.33 USD, with revenue projected to reach 13.18 million USD, implying an decrease of -48.44% EPS, and increase of 12.08% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Danaher Corporation
Report Date
Jan 28, 2026 For Q4 25
Estimate
$2.17
Actual
$2.23
Surprise
+2.56%
HCA Healthcare, Inc.
Report Date
Jan 27, 2026 For Q4 25
Estimate
$7.53
Actual
$8.14
Surprise
+8.05%
Elevance Health, Inc.
Report Date
Jan 28, 2026 For Q4 25
Estimate
$3.12
Actual
$3.33
Surprise
+6.46%
Revvity, Inc.
Report Date
Feb 02, 2026 For Q4 25
Estimate
$1.58
Actual
$1.70
Surprise
+7.45%
FAQ
What were Shoulder Innovations, Inc.'s earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Shoulder Innovations, Inc. reported EPS of -$0.64, missing estimates by -101.77%, and revenue of $11.76M, 15.57% above expectations.
How did the market react to Shoulder Innovations, Inc.'s Q3 2025 earnings?
The stock price moved up 32.04%, changed from $11.36 before the earnings release to $15.00 the day after.
When is Shoulder Innovations, Inc. expected to report next?
The next earning report is scheduled for Feb 12, 2026.
What are the forecasts for Shoulder Innovations, Inc.'s next earnings report?
Based on --
analysts, Shoulder Innovations, Inc. is expected to report EPS of -$0.33 and revenue of $13.18M for Q4 2025.